Inhaled nitric oxide usage in preterm infants in the NICHD neonatal research network: Inter-site variation and propensity evaluation

Journal of Perinatology

Volumn 34, Issue 11, 2014, Pages 842-846

  Truog, W E ^a   Nelin, L D ^b   Das, A ^c   Kendrick, D E ^c   Bell, E F ^d   Carlo, W A ^e   Higgins, R D ^f   Laptook, A R ^g   Sanchez, P J ^h   Shankaran, S ⁱ   Stoll, B J ⁱ   Van Meurs, K P ^j   Walsh, M C ^k  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTICLE; COMPARATIVE STUDY; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; INFANT; INFANT MORTALITY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREMATURITY; PREVALENCE; PROPENSITY SCORE; RESPIRATORY FAILURE; RISK ASSESSMENT; RISK FACTOR; TIME TO TREATMENT; BRONCHOPULMONARY DYSPLASIA; INHALATIONAL DRUG ADMINISTRATION; NEWBORN; STATISTICAL MODEL;

ADMINISTRATION, INHALATION; BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; MALE; NITRIC OXIDE; PROPENSITY SCORE;

EID: 84908609305     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.105     Document Type: Article

References (29)

1. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide for term and near term infants for hypoxic respiratory failure. N Eng J Med 1997; 336: 597-604
2. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006; (4): CD000399.
3. Truog WE, Castor CA, Sheffield MJ. Neonatal nitric oxide use: predictors of response and financial implications. J Perinatol 2003; 23(2): 128-132
4. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003; 349(22): 2099-2107
5. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355(4): 343-353
6. Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK et al. Inhaled nitric oxide for premature infants with severe Respiratory Failure. N Engl J Med 2005; 353(1): 13-22
7. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355: 354-364
8. Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D et al. EUNO Study Group. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a RCT. Lancet 2010; 376: 346-354
9. Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med 2005; 353(1): 23-32
10. Patrianakos-Hoobler AI, Marks JD, Msall ME, Huo D, Schreiber MD. Safety and efficacy of inhaled nitric oxide treatment for premature infants with respiratory distress syndrome: follow-up evaluation at early school age. Acta Paediatr 2011; 100(4): 524-528
11. Hibbs AM, Walsh MC, Martin RJ, Truog WE, Lorch SA, Alessandrini E et al. One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to Prevent) Chronic Lung Disease Trial. J Pediatr 2008; 153(4): 525
12. Zupancic JA, Hibbs AM, Palermo L, Truog WE, Cnaan A, Black DM et al. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics 2009; 124(5): 1325-1332
13. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2007; (12): CD000509
14. Donohoe PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD et al. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 2011; 355: 413-421
15. Askie LM, Ballard RA, Cutter G, Dani C, Elbourne D, Field D et al. Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis. BMC Pediatr 2010; 23: 10-15
16. Clark RH, Ursprung RL, Walker MW, Ellsbury DL, Spitzer AR. The changing pattern of inhaled nitric oxide use in the neonatal intensive care unit. J Perinatol 2011; 30 (12): 800-804
17. Padula MA, Grover TR, Brozanski B, Zaniletti I, Nelin LD, Asselin JM et al. Therapeutic interventions and short-term outcomes for infants with severe bronchopulmonary dysplasia born at o32 weeks gestation. J Perinatol 2013; 33: 877-881
18. Cole FS, Alleyne C, Barks JD, Boyle RJ, Carroll JL, Dokken D et al. NIH Consensus Developmental Conference Statement: Inhaled nitric oxide therapy for premature infants. Pediatrics 2011; 127: 363-369
19. Braitman L, Rosenbaum P. Rare outcomes, common treatment: analytic strategies using propensity scores. Annals Internal Med 2002; 137(8): 693-695
20. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114: 1305-1311
21. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA et al. National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-1360
22. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41
23. DAgostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med 1998; 17: 2265-2281
24. Freeman VA. Very Low Birth Weight Babies Delivered at Facilities for high-Risk Neonates: A Review of Title V National Performance Measure 17. University of North Carolina at Chapel Hill, Cecil G. Sheps Center for Health Services Research: Chapel Hill, NC, 2010
25. Stenger M, Slaughter J, Kelleher K, Shepherd E, Klebanoff M, Reagan P et al. Hospital variation in nitric oxide use for premature infants. Pediatrics 2012; 129: 945-951
26. Peliowski A and the Canadian Paediatric Society, Fetus and Newborn Committee. Inhaled nitric oxide use in newborns. Pediatr Child Health 2012; 17: 95-97
27. Kumar P and the Committee the Fetus and Newborn. Use of inhaled nitric oxide in preterm infants. Pediatrics 2014; 133: 167-170
28. Concato J. Study design and evidence in patient-oriented research. Am J Respir Crit Care Med 2013; 187: 1167-1172
29. Albert RK. Lies, damned lies and observational studies in comparative effectiveness research. Am J Respir Crit Care Med 2013; 187: 1173-1177.